Publication | Open Access
Apatinib versus sorafenib in patients with advanced hepatocellular carcinoma: a preliminary study
23
Citations
23
References
2020
Year
Compared with sorafenib, apatinib yielded comparable PFS and OS, and even better ORR, in patients with advanced HCC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1